Showing 1 - 14 results of 14 for search 'Bhagirathbhai Dholaria', query time: 0.08s
Refine Results
-
1
Emerging therapeutic agents for lung cancer by Bhagirathbhai Dholaria, William Hammond, Amanda Shreders, Yanyan Lou
Published 2016-12-01
Article -
2
-
3
-
4
-
5
-
6
-
7
Cost Analysis of R-CHOP Versus Dose-Adjusted R-EPOCH in Treatment of Diffuse Large B-Cell Lymphoma with High-Risk Features by Bhagirathbhai Dholaria, Yenny Alejandra Moreno Vanegas, Nancy Diehl, Aaron C. Spaulding, Sue Visscher, Han W. Tun, Sikander Ailawadhi, Prakash Vishnu
Published 2020-04-01
Article -
8
Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies by Aixa E. Soyano, Bhagirathbhai Dholaria, Julian A. Marin-Acevedo, Nancy Diehl, David Hodge, Yan Luo, Rami Manochakian, Saranya Chumsri, Alex Adjei, Keith L. Knutson, Yanyan Lou
Published 2018-11-01
Article -
9
S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL by Luciano Costa, Eva Medvedova, Sarabh Chhabra, Bhagirathbhai Dholaria, Binod Dhakal, Kelly Godby, Rebecca Silberman, Susan Bal, Anita D’souza, Smith Giri, Timothy Schmidt, James Omel, Parameswaran Hari, Natalie Callander
Published 2023-08-01
Article -
10
New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide by Brendan L. Mangan, Dilan Patel, Heidi Chen, Katie S. Gatwood, Michael T. Byrne, Salyka Sengsayadeth, Stacey Goodman, Bhagirathbhai Dholaria, Adetola A. Kassim, Madan Jagasia, Wichai Chinratanalab, Kathryn A. Culos, Brian G. Engelhardt
Published 2020-11-01
Article -
11
689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2 by Lien Vandenberk, Paula Rodríguez-Otero, Maria-Victoria Mateos, Ajai Chari, Bhagirathbhai Dholaria, Deeksha Vishwamitra, Sheri Skerget, M Damiette Smit, Kalpana Bakshi, Sangmin Lee, Nizar Bahlis, Niels WCJ van de Donk, Raluca Verona
Published 2023-11-01Article -
12
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara‐KRd), autologous hematopoietic cell transplantation, and measur... by Rebecca W. Silbermann, Timothy Martin Schmidt, Susan Bal, Binod Dhakal, Bhagirathbhai Dholaria, Eden Biltibo, Saurabh Chhabra, Smith Giri, Kelly N. Godby, Sonia Gowda, Eva Medvedova, Robert F. Cornell, Natalie S. Callander, Luciano J. Costa
Published 2023-08-01
Article -
13
P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) by Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, Alan S Wayne, Deepa Bhojwani, Ashish Bajel, Bhagirathbhai Dholaria, Rawan Faramand, Ryan Mattison, Michael Rettig, Ouiam Bakkacha, John Muth, Angela Pannunzio, Brett Ramsey, Eileen Mcnulty, Matthew Cooper, Jan Davidson-Moncada, Kenneth Jacobs, John Dipersio
Published 2023-08-01
Article -
14
S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS by Nizar J Bahlis, Katja Weisel, Maria-Victoria Mateos, Hartmut Goldschmidt, Tom Martin, Daniel Morillo, Donna Reece, Paula Rodríguez-Otero, Manisha Bhutani, Anita D’souza, Albert Oriol, Laura Rosiñol Dachs, Bhagirathbhai Dholaria, Kalpana Bakshi, Lijuan Kang, Lien Vandenberk, Damiette Smit, Ralph Wäsch, Niels W.C.J. van de Donk, Ajai Chari
Published 2023-08-01
Article